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Xenopus oocytes were used to examine the coupling of 
the serotonin IC (5HTlc) and thyrotropin-releasing  hor- 
mone  (TRH) receptors  to  both endogenous and heterolo- 
gously expressed G protein a subunits. Expression of 
either G protein-coupled  receptor  resulted in agonist- 
induced, Ca2+-activated C1- currents  that were  measured 
using a two-electrode voltage clamp. BHT-induced C1- 
currents were  reduced 80% by incubating  the  injected 
oocytes with  pertussis toxin (PTX) and inhibited 50-65% 
by injection of antisense oligonucleotides to the PTX- 
sensitive Go a subunit. TRH-induced C1- currents were 
reduced only 20% by PTX treatment  but were inhibited 
60% by injection of antisense oligonucleotides to the 
PTX-insensitive Gq a subunit.  Injection of antisense ol- 
igonucleotides to a novel Xenopus phospholipase C-p in- 
hibited the 5HTlc (and Go)-induced C1- current with 
little effect on the TRH (and Gq)-induced current. These 
results suggest that receptor-activated Go and Gq inter- 
act with different effectors, most likely different iso- 
forms of phospholipase C-p. Co-expression of each  re- 
ceptor with seven different mammalian G protein a 
subunit cRNAs (Goa,  Gob,  Gq, Gll, Gs,  Golf, and Gt) was 
also examined. Co-expression of either  receptor  with  the 
first four of these Ga subunits  resulted  in a maximum 
4-6-fold increase in C1- currents;  the increase  depended 
on the amount of G a  subunit cRNA injected. This in- 
crease was blocked by PTX for Gaoa and Gaob co-ex- 
pression  but  not  for Gaq or Gall co-expression. Co-ex- 
pression of either  receptor  with Gs, Golf, or Gt had no 
effect on  Ca2+-activated C1- currents;  furthermore, co- 
expression  with Gs or Golf also failed to  reveal 5HT- or 
TRH-induced changes in adenylyl cyclase as assessed by 
activation of the cystic fibrosis transmembrane con- 
ductance  regulator C1- channel. These results  indicate 
that  in oocytes, the 5HTlc and TRH receptors do  the 
following: 1) preferentially couple to PTX-sensitive (Go) 
and PTX-insensitive (Gq) G proteins  and  that these G 
proteins  act on different effectors, 2) couple within the 
same cell type to several different heterologously ex- 
pressed G protein a subunits to activate the oocyte’s 
endogenous C1- current, and 3) fail to couple to G 
protein a subunits that activate CAMP or phospho- 
diesterase. 
Heterotrimeric  guanine nucleotide-binding proteins (G pro- 
teins)  are responsible  for transducing  signals between cell sur- 
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face  seven-helix  receptors and  intracellular second messengers 
(for reviews, see Ross (19891, Simon et al. (1991), and Hille 
(1992)) or ion channels  (PfaEnger et al., 1985; Logothetis et al., 
1987; Yatani and Brown, 1989) (for reviews, see Brown and 
Birnbaumer (19901, Kurachi et al. (1992)). Cloning and  char- 
acterization of the a subunits of these G proteins  resulted  in 
subtype classifications  based  upon  amino  acid identity (Simon 
et al., 19911, second messenger activation,  and  pertussis toxin 
(PTX)’ sensitivity. Gs and Golf constitute a subfamily of G 
proteins  that  activate adenylyl cyclase and  are not modified by 
PTX (Graziano et al., 1987; Jones and Reed, 1989). The Gq 
subfamily of G proteins  activate phospholipase C-p (PLCp)  and 
are also unmodified by PTX (Strathmann and Simon, 1990; 
Smrcka et al., 1991;  Conklin et al., 1992). Another subfamily 
shares significant  amino  acid homology, but  its  members  are 
PTX-sensitive. These include  G proteins  that  inhibit adenylyl 
cyclase (Gi) (Taussig et al., 19931, activate cGMP phosphodies- 
terase  (Gt,  transducin) (Vuong et al., 1984; Chabre et al., 1988), 
and activate PLC in Xenopus oocytes (Go) (Moriarty et al., 
1990). 
The  large  number of different  seven-helix receptors, G pro- 
teins, and effectors that are often present in the same cell 
suggests that in principle, a large  number of distinct signal 
transduction  pathway combinations can be  formed. The  extent 
to  which pathway specificity is achieved for given receptors, 
heterotrimeric G proteins,  and effectors in different cell types is 
not known.  Recent investigations  have focused upon this  ques- 
tion  using  several different approaches. These  include the fol- 
lowing: 1) examining  GTP hydrolysis following reconstitution 
of purified  receptor and G proteins  in vesicles (Cerione et al., 
1986; Ueda et al., 1989; Senogles et al., 19901, 2) using  anti- 
bodies raised  against  the  C-terminal  receptor-interacting por- 
tion of G protein 01 subunits  to  inhibit coupling  (Cerione et al., 
1988; McFadzean et al., 1989; Shenker et al., 1991;  Aragay et 
al., 1992), and  3)  using different combinations of PTX treat- 
ment,  antisense “knock-out,’’ and heterologous  expression 
(Moriarty et al., 1989;  Kleuss et al., 1991;  Coupry et al., 1992; 
Duzic et al., 1992;  Blitzer et al., 1993)  and  then  examining  their 
actions on downstream effectors. 
These  approaches  have been  used to identify  which  receptors 
couple to which  G proteins, to assess  the  relative affinities of 
receptors  for various G proteins,  and  to  determine  mechanistic 
details of this interaction.  Studies of the  actions of the  same 
seven-helix receptor in different endogenous tissues estab- 
lished that coupling to second messenger systems occurs in a 
tissue-specific manner  (Bonner et al., 1988; Cantiello and 
Lanier, 1989). Cloning and heterologous  expression of specific 
seven-helix  receptors in different cell types  established  that  the 
cell-specific coupling was  not necessarily due to  different recep- 
tor isoforms but could also  be due  either  to cell-specific inter- 
The abbreviations used are: PTX, pertussis toxin; CFTR, cystic fi- 
brosis transmembrane regulator; 5HT, serotonin; PLC, phospholipase 
C; TRH, thyrotropin-releasing hormone. 
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actions of the  same G protein subtype with different second 
messenger pathways  or with  different  G  protein subtypes pre- 
sent  in  the cells. For example, the cloned neuropeptide Y re- 
ceptor  expressed  in human embryonic  kidney cells inhibits ac- 
cumulation of CAMP; in Chinese hamster ovary cells, this 
receptor acts  to  elevate  intracellular  Ca2+ levels (Herzog et al., 
1992). Moriarty et al. (1989) expressed the PLC-activating  liver 
AVP receptor  (which couples to a PTX-insensitive G  protein in 
its  native  environment)  in Xenopus oocytes and found that  it 
activated PLC via  a PTX-sensitive G  protein.  This  finding sug- 
gests  that  the  same receptor can couple to different  G proteins 
in different cell types. However, such a conversion to PTX sen- 
sitivity is  not a  necessary result of expression in oocytes. The 
al-adrenergic receptor that  in liver is PTX-insensitive (Lynch 
et al., 1986) retains its PTX insensitivity when expressed in 
oocytes (Blitzer et al., 1993). 
Xenoplts oocytes provide a convenient and  quantitative sys- 
tem for investigating  the coupling of seven-helix  receptors and 
G proteins  to  pathways involving PLC and adenylyl cyclase. To 
examine receptor/G protein activation of PLC and  its down- 
stream effectors, the oocyte's endogenous Ca2+-activated C1- 
conductance  can be measured  using  the  standard two-electrode 
voltage-clamp configuration. The C1- current  results from PLC- 
activated inositol 1,4,5-trisphosphate  release of Ca2+ from in- 
ternal  stores (McIntosh and  Catt, 1987; Gillo et al., 1987; Oron 
et al., 1988). To examine  receptor/G  protein  activation of ad- 
enylyl cyclase and  its downstream effectors, the cystic fibrosis 
transmembrane conductance regulator (CFTR) C1- channel  can 
be expressed in oocytes t o  provide an  assay  system for adenylyl 
cyclase that can also be assessed electrophysiologically. This 
channel  is  activated by protein kinase A (Welsh et al., 1992) and 
is  sensitive  to  small changes in CAMP concentration (Uezono et 
al., 1993). In this article, we have examined the receptor/(=- 
protein specificity for the serotonin IC (5HTlc)  and  thyrotropin 
releasing hormone  (TRH)  receptors, two seven-helix  receptors 
that in their endogenous tissues, couple to G proteins that 
activate PLC. We find the following: 1) the  5HTlc  and TRH 
receptors  preferentially couple to endogenous, PLC-activating 
G proteins  in  the oocyte that  are PTX-sensitive (Go) and PTX- 
insensitive  (Gq),  respectively;  2) these two G proteins act 
through distinct downstream effectors (most likely different 
PLC isoforms) that effect Ca2+-activated C1- currents;  3)  the two 
receptors can couple to  other, heterologously expressed mam- 
malian G  protein a subunits  to  activate inositol  1,4,5-trisphos- 
phate-mediated C1- currents;  and  4)  these two receptors fail to 
couple to heterologously expressed  G  protein a subunits  that 
activate CAMP or phosphodiesterase. 
EXPERIMENTAL PROCEDURES 
Preparation of Sense and Antisense Oligonucleotides-The oligonu- 
cleotides were synthesized by the Caltech Oligonucleotide Synthesis 
facility. The  sequences  encoding  the  sense  and  the  corresponding  anti- 
tides 891-918 (Olate et al., 1989); Xenopus Gaq,  nucleotides 901-931; 
sense  complementary sequence  were as follows: Xenopus Guo, nucleo- 
and Xenopus PLCp,  nucleotides 928-958 (Ma  et al., 1993). The oligo- 
nucleotides were phenol-chloroform extracted, recovered by ethanol 
precipitation, dissolved in H,O at 25 p ~ ,  and  aliquoted  and  stored at 
-20 "C. 
In Vitro Synthesis of RNA-In vitro transcription of sense RNA was 
carried out as described previously (Guastella et al., 1990) with few 
modifications. Recombinant plasmids containing cDNA inserts were 
linearized by digestion  with  appropriate  restriction  enzymes.  The tran- 
scription of linearized  templates  was  performed  in  7.6 mM Tris-HC1, pH 
7.6, 6 mM MgCI,,  0.6 mM NaCl, and  10 mM dithiothreitol  containing 0.5 
mM each of adenosine  triphosphate,  cytidine  triphosphate,  and  uridine 
triphosphate, 0.1 mM of guanosine  triphosphate, 0.5 mM of 5'-(7- 
methyl)-guanosine-guanosinetriphosphate,  and  180  units  ofthe  respec- 
tive polymerase as follows: p3Gq (Strathmann  and Simon, 1990), T3; 
pBSGll  (Strathmann  and  Simon,  1990), pML52Goa (Strathmann et  al., 
1990;  Slepak  et  al.,  1993), pML52Gob (Strathmann et al., 1990; Slepak 
et al.,  1993), pBSmTRHR (Straub  et al., 1990), and  pBS5HTlc, "7; in  a 
total volume of 250 pl. The  reaction  mixture  was  incubated for 150  min 
a t  37 "C. The DNA template  was  subsequently removed by treatment 
with 5 units of RNase-free  DNase I (Promega) for 15  min at 37 "C. Free 
nucleotides  were  removed  using a Sephadex G50 column.  The mRNA 
was phenol-chloroform-extracted and recovered by ethanol precipita- 
tion.  The RNA was dissolved in  RNase-free  water,  aliquoted,  and  stored 
a t  -70 "C until  used. 
Oocyte Expression and Electrophysiology-These procedures  are de- 
scribed in detail elsewhere (Quick and Lester, 1994). Briefly, oocytes 
were  defolliculated  and  maintained at  18 "C in  incubation  medium con- 
taining ND96 (96 mM NaCI, 2 mM KCI, 1 mM MgCI,, 5 mM HEPES pH 
7.41, 1.8 mM CaCl,, 50 pg/ml gentamycin,  and 5% horse  serum  (Quick  et 
al., 1992). Twenty-four hours prior to electrophysiological assay, the 
oocytes were  transferred to incubation  medium  without  horse  serum. 
Unless  otherwise  noted,  measurements were performed 48-72 h post- 
injection. Whole cell currents were measured a t  room temperature US- 
ing  a  Dagan  8500  amplifier  in  a  standard two-microelectrode voltage- 
clamp  configuration.  Current  was  measured on-line by oscilloscope and 
chart recorder. Electrodes  were filled with 3 M KC1 and  had  a  resistance 
of 1-2 ~ n .  During  the  experiment,  the oocytes were clamped a t  -80 mV 
and  superfused  continuously  in ND96 medium; all drugs  were  applied 
in  this  solution. 
Materials-TRH was from Peninsula Laboratories (Belmont, CA), 
5HT  was from Research Biochemicals Incorporated  (Natick, MA), and 
PTX was from List Biological Laboratories (Campbell, CA). All other 
drugs  and  reagents  were from Sigma. 
RESULTS 
Xenopus oocytes expressing either  5HTlc or TRH receptors 
voltage clamped at  negative  holding potentials (-80 mV) pro- 
duced an  inward  current when  superfused  with the  appropriate 
agonist. Examination of the waveforms (Fig. lA) of these  re- 
sponses showed that  they  are  characteristic of the PLC- and 
inositol 1,4,5-trisphosphate-mediated Ca2+-activated C1- con- 
ductance  (Miledi and  Parker, 1984; Dascal et al., 1986; Mori- 
arty  et al., 19891, namely, a rapid  transient  inward  current  that 
returns to pre-agonist background levels in the presence of 
agonist. The waveforms generated by the two receptors  did  not 
show any noticeable differences. Application of either 5HT or 
TRH to uninjected oocytes failed to elicit these  currents  (data 
not shown). 
Injection of increasing  amounts of either receptor resulted  in 
larger agonist-induced peak inward currents (Fig. lB) that 
otherwise exhibited the  same waveform. As little as 5 pg of 
5HTlc receptor cRNA and 50 pg of TRH receptor cRNA pro- 
duced inward  currents of several hundred  nanoamps (827 * 128 
nA and 273 f 90 nA, respectively). With cRNA injection amount 
plotted on a log scale, there was an approximately linear  in- 
crease in the peak inward currents for both receptors as a 
function of the log of the  amount of injected cRNA. For oocytes 
injected with 500 pg of 5HTlc receptor cRNA, application of 1 
nM 5HT resulted  in peak currents of approximately  3 pA (3050 
2 270 nA); for oocytes injected with 1 ng of TRH receptor cRNA, 
application of 10 nM TRH resulted  in comparable  peak currents 
(2260 * 218 nA). In  the  experiments described below, oocytes 
were injected with  amounts of receptor cRNA that would prod- 
uce responses in this log-linear range in order to allow for 
sensitive  detection of changes in  the agonist-induced inward 
currents  as a result of various  experimental treatments. 
The effect of  PTX treatment on the agonist-induced inward 
currents of oocytes injected with  both receptors is shown in Fig. 
2. PTX treatment  resulted  in a strong inhibition of the 5HT- 
induced current (18% of non-PTX treated control oocytes) with 
little effect on the TRH-induced current (83% of non-PTX 
treated controls). Agonist applications  were performed a t  5-min 
intervals, and the order of agonist presentations was alter- 
nated on different oocytes; this was done to eliminate the pos- 
sibility that  the  measured effects were due to desensitization of 
the oocyte as a result of multiple  agonist  applications. I t  should 
also be noted that  neither application of 5HT to TRH receptor- 
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FIG. 1. Agonist-induced inward currents in oocytes injected 
cordings  from  individual oocytes injected  with  either  50 pg of 5HTlc or 
the  start of a 20-s application of either 1 nM 5HT  or  10 nM TRH. B ,  
200 pg of TRH  receptor cRNA. The solid burs uboue each truce represent 
various  amounts of injected  receptor cRNA. 5HT  and  TRH  concentra- 
dose-response  relations for the  magnitude of inward  current  elicited for 
tions  were 1 and 10 nM, respectively. Data  are  the  mean 2 S.E. for 7-12 
oocyteddata  point. 
injected oocytes nor application of TRH to 5HTlc receptor- 
injected oocytes elicited any  currents  (data  not shown), sug- 
gesting that each  receptor is specific for its  appropriate ligand. 
The differential reduction due to PTX in  the 5HTlc-induced 
current uersus the TRH-induced current in oocytes injected 
with both receptors  eliminates  systematic  errors  due  to pos- 
sible nonspecific toxic effects produced by  PTX. These  findings 
suggest  that  in co-injected oocytes, the  5HTlc receptor  prefer- 
entially couples to an  endogenous PTX-sensitiue G protein that 
activates PLC, and  the TRH receptor  preferentially couples to 
an endogenous PTX-insensitive G protein that  activates PLC. 
Go is a PTX-sensitive G protein subtype  that is linked to  
phosphoinositol turnover  in Xenopus oocytes (Moriarty et al., 
1990) and also activates a novel PLC-p isoform in oocytes (Ma 
et al., 1993). These findings  suggested that the  SHTlc receptor- 
mediated  response  might occur via the oocyte’s endogenous Go. 
This hypothesis was  tested  using  antisense oligonucleotides to  
the Go a subunit,  and  the  results  are shown in Fig. 3 A .  When 
1000 r 
10% 5HT 
0 10% TRH 
k 
X 
a 
+ 
T 
oocytes  injected  with SHTlc and TRH receptor cRNA. Oocytes 
FIG. 2. The effect of PTX incubation  on  the  inward  currents  in 
were  injected  with  both 5 pg of 5HTlc  and 50  pg of TRH  receptor cRNA. 
Approximately 1 day after injection, oocytes were placed in medium 
containing 5 pg/ml PTX for 24 h. Currents  induced by 5HT (1 nM) or by 
TRH  (10 nM) were then  measured  and  compared  with  those for oocytes 
not  incubated  in PTX. Multiple  agonist  applications  were  made at 5-min 
to  eight oocytesicondition. Similar  results  were  obtained  in  three  other 
intervals.  The  data  are  mean 2 S.E. for an  individual oocyte batch, five 
batches. 
compared with receptor-injected oocytes that were co-injected 
with 25 ng of the  sense oligonucleotide corresponding to the Go 
a subunit, oocytes co-injected with  the  same  amount of anti- 
sense oligonucleotide showed reduced peak  inward C1- currents 
(Fig. 3A) .  The maximum effect of this reduction occurred ap- 
proximately 1-2 days following injection of the oligonucleotide, 
which agrees  with previous studies examining antisense 
knock-out of G protein a! subunits  (Kleuss et al., 1991;  Blitzer et 
al., 1993). The ligand-induced current found in antisense- 
treated oocytes recovered to the levels found in control oocytes 
(sense oligonucleotide-injected) 3 4  days following injection. 
These effects are  due  to  the low turnover  time  and  synthesis 
rate of the G protein. As was  seen  with  the ffect of PTX treat- 
ment, oocytes expressing the  5HTlc receptor  were  much  more 
sensitive  to  the effects of Go a subunit  antisense oligonucleo- 
tides  than oocytes expressing the TRH  receptor (Fig. 3A). 
The difference in coupling preference  between the  5HTlc  and 
TRH receptors for endogenous G proteins  in oocytes as revealed 
by antisense knock-out experiments  is more clearly observed in 
oocytes co-injected with both  receptors. In  measurements  made 
48 h following oligonucleotide injection, oocytes injected with 
25 ng of Go a subunit  antisense (Fig. 3B) showed 5HT-induced 
peak  inward  currents  that were 34%  of control, sense-injected 
oocytes. On the  other  hand,  these  same oocytes showed peak 
inward  currents  that  were 77% of sense-injected oocytes when 
superfused with TRH. These results suggest that a Go sub- 
type(s) endogenous to  the oocyte preferentially couples to  the 
5HTlc receptor. 
Gq is a PTX-insensitive G protein that  is found in oocytes; 
the limited effect of PTX treatment on the TRH-induced cur- 
rents  in oocytes co-expressing 5HTlc  and TRH receptors  sug- 
gested that Gq may be mediating  the TRH response. We tested 
this hypothesis  directly using  antisense oligonucleotides to  the 
oocyte Gq a subunit,  and  the  results  are  presented  in Fig. 3C. 
TRH-induced currents  in oocytes injected  with Gq a antisense 
oligonucleotides 48  h  prior to  measurement were  reduced by 
62% compared with sense-injected controls. By comparison, 
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and/or TRH receptor cRNA. A,  oocytes were  first  injected  with  either  10  pg of 5HTlc  or 50  pg of TRH  receptor. Twenty-four hours  later,  the 
FIG. 3. The effect of Go a, Gq a, or PLCp antisense oligonucleotide injection on the inward currents in oocytes injected  with 5HTlc 
oocytes were  injected  with 25 ng of Go CY antisense oligonucleotide. Agonist-induced  inward  currents  (10 nM 5HT  or  100 nM TRH)  were  measured, 
point). B-D, oocytes were  injected  with  both 5 pg of 5HTlc  and 50  pg of TRH receptor cRNA and injected  24  h later  with  25  ng of antisense 
and  the  results  are plotted as a  function of time following antisense  injection  (mean * S.E. for three  batches of oocytes, four  to  seven  oocyteddata 
oligonucleotides to Go a ( B ) ,  Gq a (C), or PLC-Xp (Dl. Multiple agonist applications were made in 5-min intervals, 48 h after antisense 
oligonucleotide injection.  The  data  (with  and  without  antisense)  are  mean * S.E. for an  individual oocyte batch, five to  eight oocytes/condition. 
with  25  ng of the comparable  sense oligonucleotide. 
Similar  results  were  obtained for three  other  batches.  In  all  cases,  the  induced  currents  were  compared  with  receptor-injected oo ytes co-injected 
5HTlc-induced  currents  were reduced by only 28% compared Because  both 5HTlc (Go) and TRH  (Gq)  receptor stimulation 
with control oocytes treated  with  the corresponding sense oli- results  in  activation of the  same Ca2+-activated C1- response in 
gonucleotide. Therefore, in dual receptor-injected oocytes, the oocytes, the most obvious question  was  whether  the Go and Gq 
majority of the TRH response is mediated  through Gq. activation converged directly on the  same effector. To examine 
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FIG. 4. Co-injection  of cRNA for re- 
ceptors and cRNA for the mammalian 
a subunits of Goa,  Gob,  Gq, and G11 
(effect on agonist-induced inward 
currents). A, oocytes were  injected  with B. 
10 pg of 5HTlc receptor  alone  or  in com- 
bination  with 1 ng of various  mammalian 
G protein 01 subunits.  The  5HT  concentra- 
tion was 10 nM. Data  are  mean  S.D. for 
an individual oocyte batch, five oocytes/ 
condition. Comparable results were ob- 
tained in experiments  using  the  TRH  re- 
of 5HTlc or 100 pg of TRH  receptor cRNA 
ceptor. B,  oocytes were  injected  with 10 pg 
alone  or  in  combination  with  various 
amounts of G protein a subunit cRNA. 
Data are mean t S.E. for two to three 
oocyte batchesK  protein  subtype  injected, 
four to nine  oocyteskondition. 
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this, we injected dual receptor-injected oocytes with  antisense 
specific for a novel Xenopus PLCp (PLC-Xp) that in oocytes 
mediates  the PTX-sensitive  response. This  antisense oligonu- 
cleotide corresponds to a region that is distinct for PLC-Xp in 
comparison with  mammalian PLC-p1, -02, and -63, and injec- 
tion of this oligonucleotide in oocytes has been  shown to  reduce 
the  amount of PLC-X@ mRNA (Ma et al., 1993). Measured 48 h 
after  antisense oligonucleotide injection, 5HT-induced currents 
were reduced by  66%; TRH-induced currents  were reduced by 
32% (Fig. 3D).  
The  preferential coupling of the  5HTlc  and TRH receptors  to 
native, presumably PLC-activating G proteins in the oocyte 
that are PTX-sensitive (Go) and PTX-insensitive (Gq), respec- 
tively, prompted us to  ask  whether  these receptors could also 
couple to other G proteins that activate PLC (ie. could this 
preference  be overridden by heterologous  expression of other G 
protein a subunits?). This was accomplished by co-injecting 
oocytes with receptor cRNA and cRNA encoding  different mam- 
malian G protein a subunits (each cloned from mouse). The 
results for oocytes injected  with 10 pg of 5HTlc receptor  alone 
1 2 3 1 5  
Mo 
2 M  f0 8 SHTlC TRH receptor  receptor 
0 ,  
0 1 1 3 1 5  
mo 
G a l  1 r 0 8 SHTlC TRH receptor  receptor 
0 1  ' 
0 1 2 J . S  
amount of injected Ga cRNA (ng) 
or in combination with 1 ng of individual G protein a subunits 
are shown in Fig. 4A. Both of the PTX-sensitive Go a subunits 
(Goa and Gob, two splice variants  that differ in  the receptor- 
interacting  C-terminal portion of the deduced protein  se- 
quence) (Strathmann et al., 1990), the PTX-insensitive Gq a 
subunits, and the PTX-insensitive G11 (Y subunits increased 
the BHT-induced peak  inward  currents everalfold over oocytes 
injected with  5HTlc receptor  alone.  Comparable results were 
found for oocytes injected with the TRH receptor and these 
same G protein a subunits (data not shown). The effect of 
different amounts of injected  G protein a subunit cRNA on the 
agonist-induced currents  mediated by both the  5HTlc  and TRH 
receptors  is shown in Fig. 4B. Increases  in  peak  inward cur- 
rents of 4-6-fold (above  control oocytes injected with receptor 
alone) were observed with each G protein a subunit tested, 
suggesting  that  these receptors can couple to  several different 
mammalian G proteins  that  activate PLC. 
Further evidence for coupling of these seven-helix receptors 
to  different mammalian G protein a subunits  in oocytes comes 
from experiments  in which  heterologous  G protein a subunit 
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FIG. 5. Effect of PTX treatment on the agonist-induced inward 
protein u subunit cR.NA.A, oocytes were injected with 10 pg of 5HTlc 
currents in oocytes injected with receptor and mammalian G 
receptor cRNA alone or in  combination  with 2 ng of Gob or Gq a subunit 
cRNA. A subset of oocytes was then  incubated  with 5 pg/ml PTX for 24 
h prior to  measurement.  The  5HT  concentration was 10 nM. The data 
are mean f S.E. for  two oocyte batches, five to  eight  oocytes/condition. 
B ,  same as A, except the oocytes were injected with 100 pg of TRH 
receptor. The  agonist  concentration was 100 m. 
expression  was combined with PTX treatment. These results 
for 5HTlc receptor-injected oocytes are  illustrated  in Fig. 5A. 
As shown above, 5HT-induced inward  currents were  reduced 
74% following 24  h of PTX treatment. When  2 ng of  cRNA for 
the PTX-sensitive Gob a subunit was co-expressed with the 
5HTlc receptor, the 5HT-induced currents were increased 
3-fold. These  currents were blocked by 78% with PTX treat- 
ment. However, the 3-fold increase  in BHT-induced inward cur- 
rents  due  to co-expression of 2 ng of the PTX-insensitive Gq a 
subunit were blocked by only 13% following PTX treatment. 
Comparable results  were found in  similar  experiments involv- 
ing  the TRH receptor  (Fig. 5B). Treatment of oocytes injected 
with receptor alone resulted in TRH-induced currents that 
were mostly  PTX-insensitive (22% reduction). PTX sensitivity 
of the TRH-induced currents could be achieved with co-injec- 
tion of the Gob a subunit;  the  greater  than 2-fold increase in 
inward currents was eliminated by PTX treatment. On the 
other  hand,  the 2-fold increase  in TRH-induced currents fol- 
lowing co-expression of the Gq a subunit  was unaffected by 
PTX treatment. 
These  results  demonstrate  that several  different exogenous 
G protein a subunits can couple to exogenously expressed 
seven-helix  receptors. However, under  these conditions, the re- 
ceptor  cannot distinguish between  PTX-insensitive and PTX- 
sensitive G protein 01 subunits. The experiments using anti- 
sense oligonucleotides to PLC-Xp demonstrated a significant 
reduction in C1- currents via the 5HTlc/Go-mediated pathway 
and  less of an effect upon  TRWGq-mediated C1- currents,  sug- 
gesting that the oocyte’s endogenous Go and Gq may act 
through different effectors. These two results prompted us  to 
ask  whether a similar  pathway segregation occurs with  heter- 
ologous expression of mammalian Go and Gq a subunits. 00- 
cytes  were  injected  with  10 pg of 5HTlc alone or in combination 
with 2 ng of Gob or Gq. Twenty-four hours  later, a subset of 
these oocytes was injected  with 25 ng of antisense oligonucleo- 
tide to PLC-Xp (Ma et al., 1993). Measured 48 h later, co- 
expression of both Go and Gq resulted  in 2-2.5-fold increases  in 
5HT-activated C1- currents compared with oocytes injected 
with  5HTlc receptor  alone.  Injection of the  antisense oligonu- 
cleotide to PLC-Xp resulted  in a 50-65% reduction in  the C1- 
currents of mouse Gob-injected oocytes; oocytes injected  with 
mouse Gq showed a  reduction in C1- currents of 0 4 0 %  (data 
not shown).  These results,  although  variable, suggest that  the 
heterologously expressed  G  protein a subunits  are acting 
on separate  downstream effectors, as  was seen  with the 
endogenous G protein a subunits. 
The ability of both the  5HTlc  and TRH receptors to couple to 
several different exogenously expressed  G  protein a subunits 
raised  the possibility that heterologous overexpression could 
result  in a complete loss of specificity between  receptor and G 
protein. Thus, G  protein a subunits  that typically exert  their 
effects on other second messenger pathways might  also couple 
to  these receptors when overexpressed in  the oocyte system. 
Therefore, oocytes were injected with  either eceptor  alone or in 
combination with various amounts of the a subunits for Gs, 
Golf, or Gt. Results for experiments involving the  5HTlc recep- 
tor  are shown in Fig. 6A (similar  results were found for experi- 
ments  using  the TRH receptor). The  currents elicited in  the 
presence of 5HT for oocytes co-injected individually  with these 
three G proteins were indistinguishable from the  currents for 
oocytes injected with receptor  alone.  These results  demonstrate 
either  that  these G  proteins do not couple to  the receptors or,  if 
they couple, they fail t o  activate  the endogenous Caz+-activated 
C1- conductance. 
For oocytes injected with  Gs or Golf, it  was more likely that 
coupling to  the  5HTlc or TRH receptors would reveal itself 
through changes in  the normal effector of these G proteins, 
adenylyl cyclase. To examine this possibility, oocytes were in- 
jected with CFTR, a C1- channel  that  can be activated  via the 
adenylyl cyclase-CAMP-protein kinase A  pathway, resulting  in 
a slow inward  current  that  can be assessed electrophysiologi- 
cally and distinguished from the faster,  endogenous  Ca2+-acti- 
vated C1- response (Uezono et al., 1993). When 1 ng of CFTR 
cRNA was co-injected with 10 pg of cRNA encoding the p2- 
adrenergic receptor, a seven-helix  receptor that couples to GS to 
activate adenylyl cyclase, application of 100 VM isoproterenol 
resulted  in  inward  currents of approximately 500 nA. Co-injec- 
tion of 5 ng of Gs a subunit cRNA increased this response 
2-3-fold (data not  shown).  These results verified that we could 
use CFTR as a sensor for Gs activity and  established  that our 
Gs cRNA was being  functionally  expressed in oocytes. 
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5HTlc receptor cRNA and cRNA for 
FIG. 6. Effect of co-iqjection of 
the a subunits of Gs, Golf, and Gt on 
SHT-induced inward currents. A, oo- 
cytes  were  injected  with 10 pg of 5HTlc 
receptor cRNA alone or in combination 
with various amounts of mammalian G 
protein a subunit cRNA. The  5HT concen- 
tration  was 10 nM. The  data  are  mean * 
S.E. for three oocyte batchedeach G pro- 
tein  subtype  injected, five oocytes/ 
tive oocyte injected  with 10 pg of 5HTlc 
condition. B,  recording for a  representa- 
receptor, 10 pg of &-adrenergic  receptor, 5 
ng of Gs a subunit, and 1 ng of CFTR 
cRNA. The arrows above each  trace  rep- 
resent  the  start of a 15-s application of 
either 100 nM 5HT  or 100 PM isoprotero- 
nol. 
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To test for coupling between the 5HTlc receptor and Gs, 
oocytes were injected  with cRNA encoding the  5HTlc receptor, 
the a subunit of Gs, and CFTR. Application of 100 nM 5HT 
resulted  in  inward  currents  that were  associated with  the en- 
dogenous C1- channel; however, there was no CFTR response 
(data  not shown) (see also, Uezono et al. (1993)). To verify that 
all heterologous components were functionally  expressed, oo- 
cytes  were  injected with cRNAs encoding the  5HTlc  and P2- 
adrenergic receptors, the a subunit of Gs, and CFTR. The  re- 
sults  are  illustrated  in Fig. 6B. Application of 5HT resulted  in 
the expected Ca2+-activated C1- current; once again,  there  was 
no Gs activation of CFTR. However, application of isoproterenol 
(and activation of the P2-adrenergic  receptor) produced a 
slowly activating  inward  current  that  is a sociated  with CFTR 
stimulation (Uezono et al., 1993). Similar  results were  obtained 
in  experiments  using  the TRH receptor and  the a subunit of 
Golf (data  not shown). These  findings  suggest that  the  5HTlc 
(and TRH)  receptor  fails to couple to G  proteins that  activate 
non-PLC pathways  in oocytes, even  when these non-PLC path- 
ways can be activated via other seven-helix  receptors. 
DISCUSSION 
TheXenopus oocyte has been a model system for understand- 
ing how specificity is achieved among seven-helix receptors, 
heterotrimeric G proteins, and downstream effectors. Exoge- 
nous  receptors can be coupled to either endogenous or exoge- 
nous G proteins to evoke native or experimentally-created 
second messenger  cascades that  can be assayed electrophysi- 
ologically with  extreme sensitivity. The best characterized of 
these  pathways is GoPLCP-mediated  and  results  in Ca2+-acti- 
vated C1- currents; most mammalian receptors that lead to 
phospholipase  C  activation elicit a PTX-sensitive response  (via 
Go) when expressed in  the Xenopus oocyte system,  although 
many of these receptors are PTX-insensitive in their native 
environment (Blitzer et al., 1993). In  this  article, we present 
evidence that two different  receptors (5HTlc  and TRH),  when 
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Gs, Golf, Gt 
2 
5HTlc Receptor + Go >> Gq + 
PLC-xp 
PLC-p? 
TRH Receptor + Gq >> Go 
FIG. 7. Summary diagram of our data examining the interac- 
tion among receptors, G proteins, and effectors in Xenopus 
oocytes. The 5HTlc preferentially couples to Go, which activates a 
recently cloned Xenopus PLCp (PLC-Xp) (Ma et al.,  1993). The  TRH 
receptor  preferentially  couples  to Gq.  Gq does not  act  through PLC-Xp 
but  most  likely  through  some  other PLCp isoform. Although  each  re- 
ceptor  shows a preference for a  particular G protein,  they  also  appear  to 
couple  to  other,  but not all, G protein  subtypes. 
co-injected in oocytes, activate C1- channels via separate  path- 
ways. The 5HTlc receptor preferentially couples to the GO/ 
PLCp  pathway; on the  other  hand,  the TRH receptor  preferen- 
tially couples to Gq and induces C1- currents  that  are largely 
independent of the Go-activated  PLCp.  These results  are  sum- 
marized in Fig. 7. Interestingly, the preference of these recep- 
tors for the oocyte’s endogenous PTX-sensitive and PTX-insen- 
sitive  G proteins, respectively, can  be eliminated by co- 
expression of some, but not all,  individual exogenous G  protein 
a subunits. 
When the  5HTlc receptor is expressed in oocytes, agonist 
application results  in  the activation of a PTX-sensitive path- 
way leading to C1- currents.  This  is consistent with findings 
that  many exogenously expressed  seven-helix  receptors  prefer- 
entially couple to an endogenous Go subtype in the oocyte 
(Blitzer et al., 1993). Using antisense oligonucleotides to the a 
subunit of the oocyte’s Go, we have similarly found that  the 
majority of the 5HT-induced C1- current  is  due  to Go; these 
results  are consistent  with the PTX results.  Neither  the PTX 
experiments nor the  antisense  experiments  resulted  in a com- 
plete  abolition of the 5HT-induced current. Although the resid- 
ual  current (approximately 20%) is very likely caused by in- 
complete elimination of the Go-mediated response, it  is also 
possible that the residual current is due to activation of a 
PTX-insensitive  G  protein by the  5HTlc receptor. 
The TRH receptor in its native environment (mammalian 
pituitary cells) is  insensitive  to PTX; interestingly, we find that 
this preference is  retained when the cloned receptor is co-ex- 
pressed in oocytes along with the  5HTlc receptor. The CCK 
receptor  also stimulates PLC through a PTX-insensitive path- 
way (Moriarty et al., 1989), and  this  characteristic  is imilarly 
retained when the oocytes are injected with  total  brain RNA. 
However, in  the CCK experiments  there  was no assessment of 
the role of exogenous G  protein subunits encoded by the  total 
brain RNA in  mediating  the PTX-insensitive  response. Using 
antisense oligonucleotides to the oocyte’s endogenous Gq a sub- 
unit, we find that  the majority of the TRH-induced current  is 
mediated via the PTX-insensitive Gq subtype. Our  results show 
a clear difference in the behavior of the  5HTlc  and TRH recep- 
tors; this difference cannot  be  due  to variability in  the Xenopus 
oocyte response, because individual oocytes co-injected with 
cRNA for both  receptors show significant differences in  their 
specific ligand-induced responses. We conclude that we have 
detected  a  preference for the coupling of the TRH receptor and 
the  5HTlc receptor to Gq and Go, respectively. 
Despite the preference in coupling of the TRH receptor to Gq 
and  the  5HTlc receptor to Go, a portion of the  current elicited 
by either receptor could not be inhibited by the  appropriate G 
protein a subunit  antisense oligonucleotide. These results may 
be due to nonspecific effects of the treatment conditions or 
could be due  to coupling of these receptors to  several different 
G protein subtypes in the oocyte. This promiscuity may be 
related to cell-specific interactions between individual recep- 
tors and G  proteins. Changes  in  the relative  concentrations of 
receptors and G proteins or co-localization of individual recep- 
tors and G proteins  in different cell types may influence the 
signaling  pathway for a given receptor. This  hypothesis is con- 
sistent  with  our  results obtained from the co-injection of recep- 
tors with cRNAs encoding various mammalian G protein a 
subunits. In these experiments, each receptor preferentially 
coupled to  the over-expressed G  protein a subunit  as  though a 
change in the concentration of G protein a subunits in the 
oocyte alters  the  nature of complexes formed between a given 
receptor and its preferred G protein. However, even though 
there  is cross-talk  between some G  proteins and receptors, the 
amount of G  protein is  not  the single determinant  in receptodG 
protein coupling. For  example, neither  the TRH nor the  5HTlc 
receptor couples to exogenously expressed Gs or Golf in oocytes, 
suggesting  that  there  are lso specific recognition sites between 
receptor and G  protein. 
We detected no differences in TRH-induced currents between 
oocytes co-injected with  the TRH receptor and G11 or Gq, in 
contrast to previous reports (Lipinsky et al., 1992). This dis- 
crepancy  may be caused by different levels of expressed TRH 
receptor or by different ratios of injected receptor:G protein a 
subunit.  In our experiments,  the injected TRH receptor cRNA 
concentration  was 5-200 times less than  that used by Lapinsky 
et al. (1992). Furthermore,  the  ratio of injected receptor:G pro- 
tein cRNA in our  experiments was  much  less than 1, whereas 
this  ratio was greater  than or equal to 1 in  the experiments 
described by Lapinsky et al. (1992). Thus, large quantities of 
receptor  may saturate downstream effectors that would other- 
wise be increased with G  protein co-expression. 
Our  experiments  tested  whether both the Go-mediated 5HT 
response and  the Gq-mediated TRH response  were elicited via 
a recently cloned Xenopus PLCP that  is known to be activated 
by Go (Blitzer et al., 1993; Ma et al., 1993). Using antisense 
oligonucleotides specific to this PLCP isoform, we found that 
there is specificity between various G protein subtypes and 
effectors, i.e. PLC-Xp antisense injections strongly inhibited 
the Go-mediated 5HT-induced current  and only weakly inhib- 
ited  the Gq-mediated TRH-induced current.  The approximately 
20% inhibition of the TRH-induced response by PLC-XP anti- 
sense  is consistent  with the idea that a fraction of this receptor 
couples to  the Go subtype. At present, we do not know what 
effector is being  activated by the Gq subtype; however, the most 
straightforward hypothesis is  that it is acting upon another 
PLC, perhaps  the oocyte counterpart to the  mammalian Gq- 
activated  PLCPl  (Berstein et al., 1992). We also do not know 
whether  the observed G  protein-mediated  responses are occur- 
ring via LY subunits or Py subunits.  The Py subunit  has been 
recently  implicated in  the activation of some isoforms of mam- 
malian PLCp (Blank et al., 1992; Camps et al., 1992a, 1992b; 
Katz  et al., 19921, and it is possible that similar activation 
occurs in Xenopus oocytes. We do know that when the cloned 
Xenopus PLCP is  transfected  in COS cells along  with  various 
mammalian py subunits, no activation of PLCp  is observed.2 
In summary, our  results  demonstrate  that specificity exists 
both at the level of receptor/G protein interactions  and at  the 
level of G proteideffector  interactions.  It will be of interest  to 
determine  the molecular mechanisms  underlying this specific- 
ity; such  findings  may  also  elucidate the mechanisms  respon- 
sible for the loss of specificity that can be achieved with G 
A. Aragay,  unpublished  results. 
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protein a subunit overexpression. 
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